May 2015

Dear shareholders and prospective shareholders,

Over the month of May, the market continued to digest our first quarter financial data, and our shift into anesthesia management services can now be quantified through financial performance metrics. We continue to proactively tell the CRH Medical story to both the investment and medical communities.

Toronto/Montreal Marketing and the Bloom Burton Conference

We attended the Bloom Burton Healthcare Investor conference in Toronto, and our CEO Edward Wright, gave a 30 minute investor presentation updating attendees on our corporate progress. We also had a full schedule of one-on-one meetings before and after the presentation. This allowed interested analysts and fund managers to meet directly with our team and have their questions answered. The Bloom Burton Conference is the preeminent healthcare investor conference in Canada, and it provided us a great setting to meet and engage with prospective investors.

Our management team also spent time in Toronto and Montreal providing corporate updates to investors who had participated in the companies March financing, as well as introducing our story to interested potential investors. We received very positive feedback regarding the expansion strategy into anesthesia the company has undertaken, and investors were supportive of management’s plan going forward.

GI Conferences

This past month, CRH attended the first of two annual national GI conferences. Digestive Disease Week (DDW), which was held in Washington DC, attracts 15,000 participants from across the U.S and around the world. This year, the O’Regan System was once again featured in the hemorrhoid therapies “hands-on” course put on by the American Society of Gastrointestinal Endoscopy. We also spend 3 days in the exhibit hall spreading the word about the CRH O’Regan System, as well as introducing CRH Anesthesia to a large GI audience for the first time. The show was a success on many levels, affording us the opportunity to garner a number of new leads for both businesses.

Thank you for your continued support, and as always if you have any questions, don’t hesitate to contact me directly.

David Matousek
Director, Investor Relations
CRH Medical Corporation
T: 800.660.2153 x 1030
W: www.crhmedcorp.com
E: dmatousek@crhmedcorp.com

We're a stable, profitable company respected by both patients and physicians. Learn more »